Exela Pharma Sciences LLC recalls .4% Sodium Bicarbonate Injection
- Published
- 2 Apr 2025
- Units affected
- 103,950 vials
- Agency
- FDA
- Country
- United States
The hazard
Lack of Assurance of Sterility
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
8.4% Sodium Bicarbonate Injection, USP, 50 mEq/50 mL (1 mEq/mL), 25 x 50 mL Single Dose Vials per carton, For Intravenous Use Only, Rx Only, Manufactured by: Exela Pharma Sciences, LLC, Lenoir, NC 28645. NDC Inner Vial: 51754-5001-1; NDC Carton: 51754-5001-4
- Brand / company
- Exela Pharma Sciences LLC
- Codes / lots
- Lots: 10006417 and 10006418, Exp. 11/30/2026
- Distribution
- Nationwide
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 2 Apr 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.